Toshiba says its equipment can detect 13 types of cancer from a drop of blood at a 99% correct rate. Toshiba has jointly developed a new diagnostic method with the National Cancer Center Institute and the Tokyo Medical University, which hopes to commercialize it within the years after the trial. This method can be used for early stage cancer treatment.
It is done by examining the type and concentration of microRNA molecules secreted by cancer cells in the blood, which can be used to detect stomach cancer, esophageal cancer, lung cancer, liver cancer, bile duct cancer, pancreatic cancer, bowel cancer, ovarian cancer, prostate cancer, bladder cancer, breast cancer, and sarcoma and glioma.
Toshiba says its chips and small devices can be diagnosed in less than two hours at a cost of less than 20,000 yen.